These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 11949271

  • 1. The use of inhaled glucocorticosteroids and recovery from adrenal suppression after systemic steroid use in a VLBW premature infant with BPD: case report and literature discussion.
    Karinski DA, Balkundi D, Rubin LP, Padbury JF.
    Neonatal Netw; 2000 Dec; 19(8):27-32. PubMed ID: 11949271
    [Abstract] [Full Text] [Related]

  • 2. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D.
    Neonatology; 2015 Dec; 107(4):358-9. PubMed ID: 26044104
    [Abstract] [Full Text] [Related]

  • 3. [Glucocorticoide therapy in premature infants: French practices in 2006].
    Autret-Leca E, Bauer S, Alberti C, Jonville-Béra AP, Aujard Y, Bensouda-Grimaldi L, Baud O.
    Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
    [Abstract] [Full Text] [Related]

  • 4. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
    Jarreau PH, Fayon M, Baud O, Autret-Leca E, Danan M, de Verdelhan A, Castot A.
    Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322
    [Abstract] [Full Text] [Related]

  • 5. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C, Bowling S, Williamson K, McGaw P, Durand M.
    Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
    [Abstract] [Full Text] [Related]

  • 6. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
    Ballabh P, Simm M, Kumari J, Califano C, Aghai Z, Laborada G, Sison C, Cunningham-Rundles S.
    Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
    [Abstract] [Full Text] [Related]

  • 7. Inhaled Corticosteroids for Bronchopulmonary Dysplasia: A Meta-analysis.
    Shinwell ES, Portnov I, Meerpohl JJ, Karen T, Bassler D.
    Pediatrics; 2016 Dec; 138(6):. PubMed ID: 27940717
    [Abstract] [Full Text] [Related]

  • 8. Bubble nasal CPAP, early surfactant treatment, and rapid extubation are associated with decreased incidence of bronchopulmonary dysplasia in very-low-birth-weight newborns: efficacy and safety considerations.
    Friedman CA, Menchaca RC, Baker MC, Rivas CK, Laberge RN, Rios EH, Haider SH, Romero EJ, Eason EB, Fraley JK, Woldesenbet M.
    Respir Care; 2013 Jul; 58(7):1134-42. PubMed ID: 23106970
    [Abstract] [Full Text] [Related]

  • 9. Update on Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia.
    Filippone M, Nardo D, Bonadies L, Salvadori S, Baraldi E.
    Am J Perinatol; 2019 Jul; 36(S 02):S58-S62. PubMed ID: 31238361
    [Abstract] [Full Text] [Related]

  • 10. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
    Chotigeat U, Ratchatanorravut S, Kanjanapattanakul W.
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
    [Abstract] [Full Text] [Related]

  • 11. Inhaled nitric oxide for premature infants with severe respiratory failure.
    Van Meurs KP, Wright LL, Ehrenkranz RA, Lemons JA, Ball MB, Poole WK, Perritt R, Higgins RD, Oh W, Hudak ML, Laptook AR, Shankaran S, Finer NN, Carlo WA, Kennedy KA, Fridriksson JH, Steinhorn RH, Sokol GM, Konduri GG, Aschner JL, Stoll BJ, D'Angio CT, Stevenson DK, Preemie Inhaled Nitric Oxide Study.
    N Engl J Med; 2005 Jul 07; 353(1):13-22. PubMed ID: 16000352
    [Abstract] [Full Text] [Related]

  • 12. Respiratory and systemic effects of inhaled dexamethasone on ventilator dependant preterm infants at risk for bronchopulmonary dysplasia.
    Pappagallo M, Abbasi S, Bhutani VK.
    Indian J Pediatr; 1998 Jul 07; 65(2):273-82. PubMed ID: 10771973
    [Abstract] [Full Text] [Related]

  • 13. Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part II. Inhaled corticosteroids alone or in combination with surfactants.
    Szabó H, Baraldi E, Colin AA.
    Pediatr Pulmonol; 2022 Apr 07; 57(4):787-795. PubMed ID: 34964564
    [Abstract] [Full Text] [Related]

  • 14. The preterm lung and airway: past, present, and future.
    Martin RJ, Fanaroff AA.
    Pediatr Neonatol; 2013 Aug 07; 54(4):228-34. PubMed ID: 23597554
    [Abstract] [Full Text] [Related]

  • 15. [Bronchopulmonary dysplasia in newborns]].
    Smagin AIu, Chernyshev AK.
    Anesteziol Reanimatol; 2004 Aug 07; (1):71-4. PubMed ID: 15206321
    [Abstract] [Full Text] [Related]

  • 16. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK, Lacaze-Masmonteil T, Valls i Soler A, Wiswell TE, Gadzinowski J, Hajdu J, Bernstein G, Sanchez-Luna M, Segal R, Schaber CJ, Massaro J, d'Agostino R, Surfaxin Therapy Against Respiratory Distress Syndrome Collaborative Group.
    Pediatrics; 2005 Apr 07; 115(4):1030-8. PubMed ID: 15805381
    [Abstract] [Full Text] [Related]

  • 17. First intention high-frequency oscillatory and conventional mechanical ventilation in premature infants without antenatal glucocorticoid prophylaxis.
    Salvo V, Zimmermann LJ, Gavilanes AW, Barberi I, Ricotti A, Abella R, Frigiola A, Giamberti A, Florio P, Tagliabue P, Tina LG, Nigro F, Temporini F, Gazzolo D.
    Pediatr Crit Care Med; 2012 Jan 07; 13(1):72-9. PubMed ID: 21499177
    [Abstract] [Full Text] [Related]

  • 18. Early inhaled nitric oxide therapy in premature newborns with respiratory failure.
    Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C, Sekar KC, Auten RL, Bhutani VK, Gerdes JS, George TN, Southgate WM, Carriedo H, Couser RJ, Mammel MC, Hall DC, Pappagallo M, Sardesai S, Strain JD, Baier M, Abman SH.
    N Engl J Med; 2006 Jul 27; 355(4):354-64. PubMed ID: 16870914
    [Abstract] [Full Text] [Related]

  • 19. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
    Lapcharoensap W, Gage SC, Kan P, Profit J, Shaw GM, Gould JB, Stevenson DK, O'Brodovich H, Lee HC.
    JAMA Pediatr; 2015 Feb 27; 169(2):e143676. PubMed ID: 25642906
    [Abstract] [Full Text] [Related]

  • 20. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM, Picaud JC, Ligi I, Blanc T, Moreau F, Pinturier MF, Zupan V, Guilhoto I, Hamon IR, Alexandre C, Bouissou A, Storme L, Patkai J, Pomedio M, Rouabah M, Coletto L, Vieux R.
    JAMA Pediatr; 2016 Apr 27; 170(4):365-72. PubMed ID: 26928567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.